Stay updated on Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial
Sign up to get notified when there's something new on the Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial page.

Latest updates to the Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial page
- Check3 days agoChange DetectedRevision history updated from v3.6.5 to v3.6.6, indicating a small deployment/maintenance update with no visible changes to the study details.SummaryDifference0.0%

- Check10 days agoChange Detected- NIH grant/contract attribution added to the study identifiers, placed beside the EudraCT number to reflect funding details in the record. This clarifies the funding source within the study's identifier block.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA new revision tag, Revision: v3.6.5, appears on the page, replacing the previous Revision: v3.6.4. This indicates a version update to the page's metadata/documentation.SummaryDifference0.0%

- Check38 days agoChange DetectedA new revision tag v3.6.4 was added and the previous tag v3.6.3 was removed, indicating an update to the page's version history.SummaryDifference0.0%

- Check59 days agoChange DetectedThis page revision upgrades from v3.6.2 to v3.6.3, indicating a deployment update. The change does not affect study details or user-facing content.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, signaling a minor version update to the page. No study content or essential details appear to be altered.SummaryDifference0.0%

Stay in the know with updates to Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Guselkumab in Psoriasis: VOYAGE 1 Clinical Trial page.